We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLX icon
451
Clorox
CLX
$12.1B
$4.57M 0.02%
28,068
+14
+0% +$2.08K
DGRW icon
452
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.6B
$4.55M 0.02%
54,631
-144
-0.3% -$11.5K
WWD icon
453
Woodward
WWD
$23.4B
$4.5M 0.02%
26,266
+6,050
+30% +$1.01M
EA icon
454
Electronic Arts
EA
$52.4B
$4.5M 0.02%
31,406
-18,364
-37% -$2.66M
APP icon
455
Applovin
APP
$135B
$4.42M 0.02%
33,867
-7,977
-19% -$728K
BX icon
456
Blackstone
BX
$103B
$4.36M 0.02%
28,505
+310
+1% +$43K
DEO icon
457
Diageo
DEO
$49.7B
$4.34M 0.02%
30,937
-323
-1% -$42K
CINF icon
458
Cincinnati Financial
CINF
$27.8B
$4.34M 0.02%
31,873
-1,951
-6% -$252K
NVS icon
459
Novartis
NVS
$302B
$4.33M 0.02%
37,613
-2,005
-5% -$228K
HUBB icon
460
Hubbell
HUBB
$24.2B
$4.31M 0.02%
10,066
-375
-4% -$144K
FCX icon
461
Freeport-McMoran
FCX
$83.9B
$4.26M 0.02%
85,373
+10,156
+14% +$458K
TTE icon
462
TotalEnergies
TTE
$192B
$4.26M 0.02%
65,891
+769
+1% +$52.3K
ECL icon
463
Ecolab
ECL
$79.2B
$4.25M 0.02%
16,642
+302
+2% +$73.9K
IFF icon
464
International Flavors & Fragrances
IFF
$20B
$4.09M 0.02%
38,985
-680
-2% -$67.8K
DLTR icon
465
Dollar Tree
DLTR
$24.6B
$4.09M 0.02%
58,119
-91,252
-61% -$8.32M
PPL
466
PPL Corp
PPL
$27.5B
$4M 0.02%
121,046
+63,218
+109% +$1.93M
VXUS icon
467
Vanguard Total International Stock ETF
VXUS
$151B
$3.99M 0.02%
61,680
-330
-0.5% -$20.4K
ALGN icon
468
Align Technology
ALGN
$12.8B
$3.92M 0.02%
15,424
-350
-2% -$82.6K
PEG icon
469
Public Service Enterprise Group
PEG
$39.1B
$3.89M 0.02%
43,612
-3,438
-7% -$274K
AIG icon
470
American International
AIG
$42.8B
$3.88M 0.02%
52,937
-3,315
-6% -$247K
SNY icon
471
Sanofi
SNY
$109B
$3.8M 0.02%
65,996
+441
+0.7% +$23.8K
SPYX icon
472
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.7B
$3.72M 0.02%
78,736
– –
WEC icon
473
WEC Energy
WEC
$36.6B
$3.7M 0.02%
38,504
-6,092
-14% -$540K
PLD icon
474
Prologis
PLD
$136B
$3.68M 0.02%
29,171
+6,905
+31% +$857K
ORLY icon
475
O'Reilly Automotive
ORLY
$75.5B
$3.64M 0.02%
47,415
-20,520
-30% -$1.51M
17 18
19
20 21

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.